Genencor Licenses Integrated Genomics' ERGO Software | GenomeWeb
NEW YORK (GenomeWeb News) — Genencor yesterday said it has licensed Integrated Genomics’ bioinformatics software.
 
IG said Genencor, a biotech segment of Danisco A/S that develops enzymes and other bioproducts, will use IG’s ERGO software to “characterize and optimize microbial products used in reducing the environmental impact of the cleaning, textiles and oil industries.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.